Valion Bio (VBIO) Receivables (2021 - 2025)
Valion Bio (VBIO) posted quarterly Receivables of $19000.0 for Q3 2025, up 111.11% year-over-year from $9000.0 in Q3 2024, and up 46.15% quarter-over-quarter from $13000.0 in Q2 2025.
Valion Bio (VBIO) Receivables (2021 - 2025) Analysis & Trends
Valion Bio's Receivables history runs 5 years deep, the most recent figure standing at $19000.0 for Q3 2025.
- In Q3 2025, Receivables rose 111.11% year-over-year to $19000.0; the TTM figure through Sep 2025 stood at $19000.0 (up 111.11% YoY), while the FY2024 annual figure was $69000.0, down 60.34% from the prior year.
- Receivables for Q3 2025 stood at $19000.0, up from $13000.0 in the prior quarter.
- The five-year high for Receivables was $174000.0 in Q4 2023, with the low at $9000.0 in Q3 2024.
- The 5-year median for Receivables is $71500.0 (2024), against an average of $68187.5.
- The sharpest annual moves came in 2024 and 2025: Receivables sank 93.13% in 2024, then soared 111.11% in 2025.
- Valion Bio's Receivables stood at $92000.0 in 2021, then rose by 16.3% to $107000.0 in 2022, then jumped by 62.62% to $174000.0 in 2023, then sank by 60.34% to $69000.0 in 2024, then slumped by 72.46% to $19000.0 in 2025.
- Business Quant data shows VBIO's Receivables at $19000.0 in Q3 2025, $13000.0 in Q2 2025, and $13000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 912.74 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 215.33 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.09 Bn |
| 10 | Valion Bio | 420,133.64 | -1.78 Mn | -45,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Mar 31, 2024 | 74,000.00 |
| Dec 31, 2023 | 174,000.00 |
| Sep 30, 2023 | 131,000.00 |
| Jun 30, 2023 | 13,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 107,000.00 |
| Sep 30, 2022 | 95,000.00 |
| Jun 30, 2022 | 92,000.00 |
| Mar 31, 2022 | 117,000.00 |
| Dec 31, 2021 | 92,000.00 |